European Union Pharmacy
 
 
Men's HealthWomen's HealthWeight LossPain ReliefAllergy ReliefDiabetesAll Products Available with PharmacyAffiliates

Show All Drugs

Newsletter
 

Opt-in for Free Newsletter, special discount offers, drugs information & latest pharmacy news.

Viagra Being Tested To Reduce Premature Births

 

Thu, 19 April 2007

Viagra—the drug that helped millions of men with erectile dysfunction, is undergoing clinical trials to reduce premature births by helping babies stay longer in the womb.

Dr. Jenny Myers, obstetrician and clinical lecturer, St Mary's Hospital, said it will be interesting if the drug works. It would be beneficial for babies affected by growth restriction for which currently there is no good treatment.

The intention is to increase blood supply to the womb and placenta so that more nutrients and oxygen could reach the foetus. This will help the foetus to continue growing in the womb and will avoid health problems that come with premature birth.

In the UK one baby born out of 12 babies have this problem.

Foetal growth restriction is a medical terminology that means a baby which is inside the womb is smaller than what he should be according to the days of pregnancy. It is believed that foetal growth restriction is caused if the mother has high blood pressure, advanced diabetes or heart disease, has the habit of smoking and taking alcohol.

During the research that was carried out in Manchester, it was found that the drug was relaxing the blood vessels that increased the blood flow.

Pfizer, the firm that manufactures Viagra, is using pregnant women whose babies have growth restriction problems for trials.

Viagra is generally used to treat erectile dysfunction in men.

 

 

 

 

UK Online Pharmacy | Patient Declaration | Waiver of Responsibility | Disclaimer | Terms and Conditions

Contact Us

©2005 EUPharma.co.uk. All rights reserved
All trademarks and registered marks are the properties of their respective companies.